Queen Sirikit National Institute of Child Health   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Bangkok Thailand (1954)

Organization Overview

First Clinical Trial
2002
NCT00192374
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kullasate Sakpichaisakul | Queen Sirikit National Institute of Child Health | Queen Sirikit National Institute of Child Health, Bangkok, Thailand | Queen Sirikit National Institute of Child Health (Children's Hospital) | Queen Sirikit National Institute of Child Health (QSNICH) | Queen Sirikit National Institute of Health

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperhomocysteinemia (Phase 4)

Infections (Phase 3)

Influenza, Human (Phase 3)

Influenza in Birds (Phase 2)

Respiratory Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 12